Blueberries Medical Corp.
Blueberries Medical Corp. (BBM.CN) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bbm.cn · pe ratio · data through Jun 10, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Blueberries Medical Corp.You BBM.CN | $5M | N/A | — | -$0.00 |
 Ayurcann Holdings Corp. AYUR.CN | $2M | N/A | — | -$0.02 |
 Christina Lake Cannabis Corp. CLC.CN | $7M | 7.30x | — | $0.00 |
 CLS Holdings USA, Inc. CLSH.CN | $8M | N/A | — | -$0.05 |
 Crescita Therapeutics Inc. CTX.TO | $15M | N/A | — | -$0.00 |
 Delivra Health Brands Inc. DHB.V | $4M | N/A | — | -$0.04 |
 Lobe Sciences Ltd. LOBE.CN | $22M | N/A | — | -$0.03 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Blueberries Medical Corp. (BBM.CN) measures how much investors pay for each dollar of the company's trailing earnings. BBM.CN's current PE ratio of N/A is calculated by dividing its stock price of $0.01 by its TTM earnings per share of -$0.00.
Frequently asked questions
BBM.CN pe ratio · 6 questionsBBM.CN's current PE ratio is N/A as of 2026-06-10, based on a stock price of $0.01 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via BBM.CN's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Blueberries Medical Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-10